Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)- infected and non-HIV-infected patients: Comparison of clinical features and review

Clinical Infectious Diseases

Volumn 26, Issue 1, 1998, Pages 91-96

  Tee, Wee ^a   Mijch, Anne ^b  

^a FAIRFIELD HOSPITAL   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; PENICILLIN DERIVATIVE;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CAMPYLOBACTER JEJUNI; CELLULITIS; CLINICAL ARTICLE; DISEASE SEVERITY; ENTERITIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOCOMPETENT CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR; SKIN MANIFESTATION;

EID: 0031914436     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516263     Document Type: Article

References (30)

1. Tee W, Kaldor J, Dwyer B. Epidemiology of Campylobacter diarrhoea. Med J Aust 1986;145:499-503.
2. Tauxe RV, Pegues DA, Hargrett-Bean N. Campylobacter infections: the emerging national pattern. Am J Public Health 1987; 77:1219-21.
3. Skirrow MB. A demographic survey of Campylobacter, salmonella, and shigella infections in England. Epidemiol Infect 1987;99:647-57.
4. Blaser MJ, Relier LB. Campylobacter enteritis. N Engl J Med 1981;305: 1444-52.
5. Nelson MR, Shanson DC, Hawkins DA, Gazzard BG. Salmonella. Campylobacter and Shigella in HIV sero-positive patients. AIDS 1992; 6: 1495-8.
6. Sorvillo FJ, Lieb LE, Waterman SH. Incidence of campylobacteriosis among patients with AIDS in Los Angeles County. J Acquir Immune Defic Syndr 1991;4:598-602.
7. Molina JM, Casin I, Hausfater P, et al. Campylobacter infection in HIV-infected patients: clinical and bacteriological features. AIDS 1995;9: 881-5.
8. Schonheyder HC, Sogaard P, Frederiksen W. A survey of Campylobacter bacteremia in three Danish counties, 1989 to 1994. Scand J Infect Dis 1995;27:145-8.
9. Dworkin B, Wormser GP, Abdoo RA, et al. Persistence of multiply antibiotic resistant Campylobacter jejuni in a patient with the acquired immune deficiency syndrome. Am J Med 1986;80:965-70.
10. Tee W, Mijch A, Wright E, Yung A. Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus. Clin Infect Dis 1995;21:634-8.
11. Perlman DM, Ampel NM, Schifman RB, et al. Persistent Campylobacter jejuni infections in patients infected with human immunodeficiency virus (HIV). Ann Intern Med 1988;108:540-6.
12. Bernard E, Roger PM, Carles D, Donaldi V, Foumier JP, Dellamonica P. Diarrhea and Campylobacter infections in patients infected with the human immunodeficiency virus [letter]. J Infect Dis 1989;159:143-4.
13. Penner J, Hennessy JN. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J Clin Microbiol 1980;12:732-7.
14. Tee W, Mayall B, Lucas CR, et al. Use of ribosomal RNA gene restriction patterns to investigate two outbreaks of Campylobacter enteritis in Melbourne, Australia. J Med Microbiol 1992;37:385-8.
15. Wang W-LL, Blaser MJ. Detection of pathogenic Campylobacter species in blood culture systems. J Clin Microbiol 1986;23:709-14.
16. Guerrant RL, Lahita RG, Winn WC, Roberts RB. Campylobacteriosis in man: pathogenic mechanisms and review of 91 bloodstream infections. Am J Med 1978;65:584-96.
17. Spelman DW, Davidson N, Buckmaster ND, Spicer WJ, Ryan P. Campylobacter bacteremia: a report of 10 cases. Med J Aust 1986;145:503-5.
18. Skirrow MB, Jones DM, Sutcliffe E, Benjamin J. Campylobacter bacteremia in England and Wales 1981-91. Epidemiol Infect 1993;110:567-73.
19. Van der Meer JWM, Mouton RP, Daha MR, Schuurman RKB. Campylobacter jejuni bacteremia as a cause of recurrent fever in a patient with hypogammaglobulinaemia. J Infect 1986;12:235-9.
20. Kerstens PJSM, Endtz HP, Meis JFGM, et al. Erysipelas-like skin lesions associated with Campylobacter jejuni septicemia in patients with hypogammaglobulinemia. Eur J Clin Microbiol Infect Dis 1992;11:842-7.
21. Borleffs JCC, Schellekens JF, Brouwer C, Rozenberg-Arska M. Use of immunoglobulin M containing preparation for treatment of two hypogammaglobulinemic patients with persistent Campylobacter jejuni infection. Eur J Clin Microbiol Infect Dis 1993;12:772-5.
22. Blaser MJ, Perez Perez G, Smith PF, et al. Extraintestinal Campylobacter jejuni and Campylobacler coli infections: host factors and strain characteristics. J Infect Dis 1986;153:552-9.
23. Slavin MA, Jennens I, Tee W. Infection with ciprofloxacin-resistant Campylobacter jejuni in travellers returning from Asia. Eur J Clin Microbiol Infect Dis 1996;15:348-9.
24. Kuschner RA, Trofa AF, Thomas RJ, et al. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis 1995;21: 536-41.
25. Gomez-Garces JL, Gogollo R, Alos JL. Susceptibilities of fluoroquinolone-resistant strains of Campylobacler jejuni to 11 oral antimicrobial agents. Antimicrob Agents Chemother 1995;39:542-4.
26. Endtz HP, Mouton RP, van der Reyden T, Ruijs GJ, Biever M, van Klingeren B. Fluoroquinolone resistance in Campylobacterspp. iso-lated from human stools and poultry product [letter]. Lancet 1990; 335:787.
27. Sjogren E, Kaijser B, Werner M. Antimicrobial susceptibilities of Campylobacler jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report. Antimicrob Agents Chemother 1992;36: 2847-9.
28. Rautelin H, Renkonen OV, Kosunen TU. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob Agents Chemother 1991;35:2065-9.
29. Taylor DM, Pitarangsi C, Echeverria P, Dinega BM. Campylobacter enteritis during doxycycline prophylaxis for malaria in Thailand. Lancet 1988; 2:578-9.
30. Petruccelli BP, Murphy GS, Sanchez JL, et al. Treatment of traveler's diarrhea with ciprofloxacin and loperamide. J Infect Dist 1992;165: 557-60.